| Epidemiological investigation of the prevalence of von Willebrand's disease F Rodeghiero, G Castaman, E Dini | 1302 | 1987 |
| A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM‐1 VWD) A Tosetto, F Rodeghiero, G Castaman, A Goodeve, AB Federici, J Batlle, ... Journal of Thrombosis and Haemostasis 4 (4), 766-773, 2006 | 595 | 2006 |
| Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis … A Goodeve, J Eikenboom, G Castaman, F Rodeghiero, AB Federici, ... Blood 109 (1), 112-121, 2007 | 472 | 2007 |
| The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study F Rodeghiero, G Castaman, A Tosetto, J Batlle, F Baudo, A Cappelletti, ... Journal of thrombosis and haemostasis 3 (12), 2619-2626, 2005 | 423 | 2005 |
| A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype F Bernardi, EM Faioni, E Castoldi, B Lunghi, G Castaman, E Sacchi, ... Blood, The Journal of the American Society of Hematology 90 (4), 1552-1557, 1997 | 326 | 1997 |
| Gene therapy with adeno-associated virus vector 5–human factor IX in adults with hemophilia B W Miesbach, K Meijer, M Coppens, P Kampmann, R Klamroth, ... Blood, The Journal of the American Society of Hematology 131 (9), 1022-1031, 2018 | 325 | 2018 |
| Early deaths and anti-hemorrhagic treatments in acute promyelocytic leukemia. A GIMEMA retrospective study in 268 consecutive patients [see comments] F Rodeghiero, G Avvisati, G Castaman, T Barbui, F Mandelli | 318 | 1990 |
| Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients AB Federici, PM Mannucci, G Castaman, L Baronciani, P Bucciarelli, ... Blood, The Journal of the American Society of Hematology 113 (3), 526-534, 2009 | 314 | 2009 |
| Congenital absence of the inferior vena cava: a rare risk factor for idiopathic deep-vein thrombosis M Ruggeri, A Tosetto, G Castaman, F Rodeghiero The Lancet 357 (9254), 441, 2001 | 303 | 2001 |
| Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent JC Gris, I Quéré, F Monpeyrou, E Mercier, S Ripart-Neveu, ML Tailland, ... Thrombosis and haemostasis 81 (06), 891-899, 1999 | 301 | 1999 |
| Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment G Castaman, AB Federici, F Rodeghiero, PM Mannucci Haematologica 88 (1), 94-108, 2003 | 277 | 2003 |
| Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A CL Eckhardt, AS Van Velzen, M Peters, J Astermark, PP Brons, ... Blood, The Journal of the American Society of Hematology 122 (11), 1954-1962, 2013 | 259 | 2013 |
| Principles of care for the diagnosis and treatment of von Willebrand disease G Castaman, A Goodeve, J Eikenboom Haematologica 98 (5), 667, 2013 | 246 | 2013 |
| Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD G Castaman, S Lethagen, AB Federici, A Tosetto, A Goodeve, U Budde, ... Blood, The Journal of the American Society of Hematology 111 (7), 3531-3539, 2008 | 235 | 2008 |
| Clinical manifestations and management of inherited thrombophilia: retrospective analysis and follow-up after diagnosis of 238 patients with congenital deficiency of … V De Stefano, G Leone, S Mastrangelo, A Tripodi, F Rodeghiero, ... Thrombosis and haemostasis 72 (09), 352-358, 1994 | 233 | 1994 |
| Guidelines for the diagnosis and management of von Willebrand disease in Italy AB Federici, G Castaman, PM Mannucci, ... Haemophilia 8 (5), 607-621, 2002 | 229 | 2002 |
| Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial E Santagostino, U Martinowitz, T Lissitchkov, B Pan-Petesch, ... Blood, The Journal of the American Society of Hematology 127 (14), 1761-1769, 2016 | 222 | 2016 |
| Detection of new polymorphic markers in the factor V gene: association with factor V levels in plasma B Lunghi, L Iacoviello, D Gemmati, MG Dilasio, E Castoldi, M Pinotti, ... Thrombosis and Haemostasis 75 (01), 045-048, 1996 | 222 | 1996 |
| Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: comparison of three different therapeutic approaches AB Federici, F Stabile, G Castaman, MT Canciani, PM Mannucci Blood, The Journal of the American Society of Hematology 92 (8), 2707-2711, 1998 | 215 | 1998 |
| Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management … U Budde, R Schneppenheim, J Eikenboom, A Goodeve, K Will, E Drewke, ... Journal of thrombosis and haemostasis 6 (5), 762-771, 2008 | 207 | 2008 |
